Prognostic role of CRP ‐independent inflammatory patterns in patients undergoing primary percutaneous interventions
European Journal of Clinical Investigation · 2023
DOI: 10.1111/eci.14000 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Clinical Investigation, 2023. Verfasst von Filippo Dossi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cardiology Unit, Lavagna Hospital, Lavagna, Italy. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Myocardial Infarction, Coronary Artery Disease, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Background
Despite the key pathophysiological role of inflammation in the development of coronary artery disease (CAD), the evaluation of inflammatory status has not been clearly established in patients presenting with acute coronary syndrome (ACS). The aim of this study is to evaluate the prevalence of CRP‐independent inflammatory patterns in patients referred for primary percutaneous coronary intervention (pPCI) and to determine their one‐year relationship with adverse clinical outcomes.
Methods
We carried out a single‐centre, observational study consecutively enrolling all patients presenting at a large‐volume PCI hub with a diagnosis of ST‐segment elevation myocardial infarction (STEMI) and treated with pPCI. Systemic immune‐inflammatory index (SII) was calculated at admission and discharge. According to different SII trajectories patients were divided into four patterns: ‘persistent‐low’, ‘down‐sloping’, ‘up‐sloping’ and ‘persistent‐high’ patterns. The primary endpoint was a composite of all‐cause of death and myocardial infarction (MI) at a one‐year follow‐up.
Results
Among the total 2353 subjects enrolled, 44% of them belonged to ‘persistent‐low’, 31% to ‘down‐sloping’, 4% to ‘up‐sloping’ and 21% to ‘persistent‐high’ pattern. The primary endpoint was observed in 8% of patients with a ‘persistent‐low’, 12% with a ‘down‐sloping’, 27% with an ‘up‐sloping’ and 25% with a persistent‐high pattern ( p = 0.001). After multivariate analysis, ‘up‐sloping’ (OR: 3.2 [1.59–3.93]; p = 0.001) and ‘persistent‐high’ (OR: 4.1 [3.03–4.65]; p = 0.001) patterns emerged as independent predictors of one‐year adverse events. Conclusions ‘Persistent‐high’ and ‘up‐sloping’ CRP‐independent inflammatory patterns in patients undergoing primary PCI are associated with an increased risk of adverse events at one‐year follow‐up. The prognostic value of these inflammatory patterns might be helpful to individualize potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Cardiology Unit, Lavagna Hospital, Lavagna, Italy.
- Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
- Cardiology Unit, Heart Centre, Fondazione Gabriele Monasterio - Regione Toscana, Massa, Italy.
ORCID-Profile: Filippo Dossi, Mario Raccis, Guido Parodi, Umberto Paradossi, Sergio Berti
Zitieren
APA
Dossi, F., Raccis, M., Parodi, G., De Caterina, A. R., Paradossi, U., Esposito, A., D'Agostino, A., De Luca, G., & Berti, S. (2023). Prognostic role of CRP ‐independent inflammatory patterns in patients undergoing primary percutaneous interventions. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14000
Vancouver
Dossi F, Raccis M, Parodi G, De Caterina AR, Paradossi U, Esposito A, et al. Prognostic role of CRP ‐independent inflammatory patterns in patients undergoing primary percutaneous interventions. European Journal of Clinical Investigation. 2023. doi:10.1111/eci.14000
BibTeX
@article{Dossi2023,
author = {Dossi, Filippo and Raccis, Mario and Parodi, Guido and De Caterina, Alberto Ranieri and Paradossi, Umberto and Esposito, Augusto and D'Agostino, Andreina and De Luca, Giuseppe and Berti, Sergio},
title = {Prognostic role of CRP ‐independent inflammatory patterns in patients undergoing primary percutaneous interventions},
journal = {European Journal of Clinical Investigation},
year = {2023},
doi = {10.1111/eci.14000}
}
EUVIMED